Structure via PubChem · Public domain (PubChem)
thiobutabarbital
Sign in to saveThiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia.
In the Vinony graph
Within Vinony's link graph, thiobutabarbital is referenced by 492 other articles, and connects out to benzodiazepine drug, isovaleric acid and allopregnanolone.
It sits within the topics Chemical pages without DrugBank identifier, Drugboxes which contain changes to verified fields and Drugs not assigned an ATC code.
Its subject is documented across 7 Wikipedia language editions.
Chemical data
- Formula
- C10H16N2O2S
- Molecular weight
- 228.31 g/mol
- IUPAC name
- 5-butan-2-yl-5-ethyl-2-sulfanylidene-1,3-diazinane-4,6-dione
- SMILES
- CCC(C)C1(C(=O)NC(=S)NC1=O)CC
- InChIKey
- IDELNEDBPWKHGK-UHFFFAOYSA-N
- XLogP
- 2.2
- Polar surface area
- 90.3 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 228.093
Show 4 more facts
- chemical formula
- C₁₀H₁₆N₂O₂S
- canonical SMILES
- CCC(C)C1(C(=O)NC(=S)NC1=O)CC
- medical condition treated
- insomnia
- Commons category
- Thiobutabarbital
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- Stereochemistry
- References
Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia.
== Stereochemistry == Thiobutabarbital contains a stereocenter and consists of two enantiomers. This is a racemate, i.e. a 1:1 mixture of (R)- and the (S)-form: {| class="wikitable" style="text-align:center" |- class="hintergrundfarbe6" ! colspan="2"| Enantiomers of Thiobutabarbital |- | 130 px (R)-Form | 130 px (S)-Form |}
Excerpted from Wikipedia’s “thiobutabarbital” article, available under the CC BY-SA 4.0 licence.